In Vitro Diagnostics Quality Control Market Size, Share & Trends Analysis Report By Product, By Type, By Application, By Manufacturer Type, By End-use, By Region, And Segment Forecasts, 2024

The global in vitro diagnostics quality control market size is expected to reach USD 1.59 billion by 2030, registering a CAGR of 3.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The continually evolving technology-oriented changes in the diagnostics field and the growing requirement to ensure patient safety necessitate the execution of quality assurance programs in several medical domains including point-of-care devices and radiology.The patients rely on self-testing in vitro diagnostics (IVD) devices for long-term disease management and hence it is important for such IVD devices to be checked for quality in terms of result reproducibility and validity to guarantee patient safety.

The rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving market growth. Some of the key pathogens routinely diagnosed using multiplex PCR, but not limited to, are HIV, HSV (meningitis and encephalitis), H. influenza, S. pneumonia (respiratory tract infections), N. gonorrhea, C. trachoma (genital infections), G. lambardia, C. parvum (diarrheal diseases), and Leishmaniaspp (Leishmaniasis).In addition to assessments, amendments to the regulatory framework are made intermittently to enhance the present standards with the main objective of safeguarding the qualitative superiority of the diagnostic services rendered to patients.

Quality control in the laboratory is focused on ensuring that the results delivered to the patient are accurate. Control checks are usually undertaken while installing an instrument, after servicing, changing reagent lots, and when the instrument readings are not in range.Home care settings include a variety of devices, such as point-of-care (PoC) instruments used for near-patient bed testing, self-testing kits, and IVD devices in assisted healthcare settings. Self-testing kits giveease of convenience for patients who require everyday testing and further reduce hospital visits.

In Vitro Diagnostics Quality Control Market Report Highlights:

In 2023, the clinical chemistry segment held the largest share of the market. The increasing demand for preventive medicine and the rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors responsible for its high market share
The quality control segment dominated the market in 2023 and is estimated to grow at the highest CAGR over the forecast period. Quality control in the research laboratory is concentrated on certifying the results provided to the individuals are precise
The hospital segment held the largest share in 2023 due to the presence of highly advanced technology-based devices, such as Next Generation Sequencing (NGS), mass spectrophotometry, and microarrays, and the rising applications of the optimized quality-control procedures
Many pharmaceutical companies are implementing the new draft guidance enforced by the U.S. FDA for data integrity on current Good Manufacturing Practices (cGMP)
It provides information in relation to establishing robust operating procedures and strong management systems, obtaining high-quality raw materials, investigating deviations, and maintaining reliable diagnostic laboratories

Product Code: 978-1-68038-925-8

Chapter 1. Methodology and Scope

1.1. Market Segmentation
- 1.1.1. Regional scope
- 1.1.2. Market definitions
- 1.1.3. Estimates and forecasts timeline
1.2. Objectives
- 1.2.1. Objective - 1
- 1.2.2. Objective - 2
- 1.2.3. Objective - 3
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
  - 1.7.1.1. Approach 1: Commodity flow approach
  - 1.7.1.2. Approach 2: Country wise market estimation using bottom-up approach.
1.8. List of Secondary Sources
1.9. List of Abbreviations

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. By Product and Type Segment Snapshot
2.3. By application and Manufacturer Type Segment Snapshot
2.4. By End-use Segment Snapshot
2.5. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising number of accredited clinical laboratories
  - 3.2.1.2. Increasing third-party quality control services
  - 3.2.1.3. Presence of favorable regulatory bodies
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High cost of IVD quality control services
  - 3.2.2.2. Unfavorable reimbursement scenario in IVD industry
- 3.2.3. Opportunity analysis
- 3.2.4. Supply chain analysis
3.3. Business Environment Analysis
- 3.3.1. PESTEL analysis
- 3.3.2. Porter's five forces analysis

Chapter 4. In Vitro Diagnostics Quality Control Market: Segment Analysis, by Product, 2018 - 2030 (USD Million)

4.1. In Vitro Diagnostics Quality Control Market: Product movement Analysis
4.2. In Vitro Diagnostics Quality Control Market Estimates & Forecast, by Product (USD Million)
- 4.2.1. Controls
  - 4.2.1.1. Total protein
  - 4.2.1.2. Albumin
  - 4.2.1.3. Blood urea nitrogen
  - 4.2.1.4. Uric acid
  - 4.2.1.5. Creatinine
  - 4.2.1.6. Sodium
  - 4.2.1.7. Potassium
  - 4.2.1.8. Chloride
  - 4.2.1.9. Calcium
  - 4.2.1.10. Magnesium
  - 4.2.1.11. Inorganic phosphorus
  - 4.2.1.12. Aspartate transaminase
  - 4.2.1.13. Creatine kinase
  - 4.2.1.14. Gamma glutamyl transferase
  - 4.2.1.15. Total bilirubin
  - 4.2.1.16. C-Reactive Protein
  - 4.2.1.17. Glucose
  - 4.2.1.18. Iron
  - 4.2.1.19. Alanine transaminase
  - 4.2.1.20. Alkaline phosphatase
  - 4.2.1.21. Alpha-amylase
  - 4.2.1.22. Total cholesterol
  - 4.2.1.23. Triglyceride
  - 4.2.1.24. Lactate dehydrogenase
  - 4.2.1.25. Immunoglobulin G
  - 4.2.1.26. Immunoglobulin A
  - 4.2.1.27. Immunoglobulin M
  - 4.2.1.28. Complement 3
  - 4.2.1.29. Complement 4
  - 4.2.1.30. Rheumatoid factor
  - 4.2.1.31. Anti-Streptolysin -O
  - 4.2.1.32. Beta 2 microglobulin
  - 4.2.1.33. Cystatin-C
  - 4.2.1.34. Myoglobin
  - 4.2.1.35. Troponin T and I
  - 4.2.1.36. Others
- 4.2.2. Calibrators
- 4.2.3. Others

Chapter 5. In Vitro Diagnostics Quality Control Market: Segment Analysis, by Type, 2018 - 2030 (USD Million)

5.1. In Vitro Diagnostics Quality Control Market: Type Movement Analysis
5.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by Type (USD Million)
- 5.2.1. Quality Controls
  - 5.2.1.1. Plasma-based control
  - 5.2.1.2. Serum-based control
  - 5.2.1.3. Whole blood-based Control
  - 5.2.1.4. Others
- 5.2.2. Quality Assurance Services
- 5.2.3. Data Management Solutions

Chapter 6. In Vitro Diagnostics Quality Control Market: By Application Estimates & Trend Analysis

6.1. In Vitro Diagnostics Quality Control Market: Application Movement Analysis
6.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by Application (USD Million)
6.3. Immunochemistry
6.4. Hematology
6.5. Clinical Chemistry
- 6.5.2. Molecular diagnostics
- 6.5.3. Coagulation
- 6.5.4. Microbiology
- 6.5.5. Others

Chapter 7. In Vitro Diagnostics Quality Control Market: By Manufacturer Type Estimates & Trend Analysis

7.1. In Vitro Diagnostics Quality Control Market: Manufacturer Type Movement Analysis
7.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by Manufacturer Type (USD Million)
- 7.2.1. Third-party controls
  - 7.2.1.1. Independent controls
  - 7.2.1.2. Instrument specific controls
- 7.2.2. OEM controls

Chapter 8. In Vitro Diagnostics Quality Control Market: End-use Estimates & Trend Analysis

8.1. In Vitro Diagnostics Quality Control Market: End-use Movement Analysis
8.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by End-use (USD Million)
- 8.2.1. Hospitals
- 8.2.2. Laboratories
- 8.2.3. Home care
- 8.2.4. Others

Chapter 9. In Vitro Diagnostics Quality Control Market: Regional Estimates & Trend Analysis, by Product, Type, Application, Manufacturer Type, and End-use

9.1. In Vitro Diagnostics Quality Control Market: Regional Outlook
9.2. North America
- 9.2.1. North America in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.2.2. U.S.
  - 9.2.2.1. Key country dynamics
  - 9.2.2.2. U.S. in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.2.2.3. Competitive/ market scenario
  - 9.2.2.4. Regulatory framework
- 9.2.3. Canada
  - 9.2.3.1. Key country dynamics
  - 9.2.3.2. Canada in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.2.3.3. Competitive/ market scenario
  - 9.2.3.4. Regulatory framework
9.3. Europe
- 9.3.1. Europe in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.3.2. UK
  - 9.3.2.1. Key country dynamics
  - 9.3.2.2. UK in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.3.2.3. Competitive/ market scenario
  - 9.3.2.4. Regulatory framework
- 9.3.3. Germany
  - 9.3.3.1. Key country dynamics
  - 9.3.3.2. Germany in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.3.3.3. Competitive/ market scenario
  - 9.3.3.4. Regulatory framework
- 9.3.4. France
  - 9.3.4.1. Key country dynamics
  - 9.3.4.2. France in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.3.4.3. Competitive/ market scenario
  - 9.3.4.4. Regulatory framework
- 9.3.5. Italy
  - 9.3.5.1. Key country dynamics
  - 9.3.5.2. Italy in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.3.5.3. Competitive/ market scenario
  - 9.3.5.4. Regulatory framework
- 9.3.6. Spain
  - 9.3.6.1. Key country dynamics
  - 9.3.6.2. Spain in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.3.6.3. Competitive/ market scenario
  - 9.3.6.4. Regulatory framework
- 9.3.7. Denmark
  - 9.3.7.1. Key country dynamics
  - 9.3.7.2. Denmark in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.3.7.3. Competitive/ market scenario
  - 9.3.7.4. Regulatory framework
- 9.3.8. Sweden
  - 9.3.8.1. Key country dynamics
  - 9.3.8.2. Sweden in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.3.8.3. Competitive/ market scenario
  - 9.3.8.4. Regulatory framework
- 9.3.9. Norway
  - 9.3.9.1. Key country dynamics
  - 9.3.9.2. Norway in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.3.9.3. Competitive/ market scenario
  - 9.3.9.4. Regulatory framework
9.4. Asia Pacific
- 9.4.1. Asia Pacific in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.4.2. Japan
  - 9.4.2.1. Key country dynamics
  - 9.4.2.2. Japan in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.4.2.3. Competitive/ market scenario
  - 9.4.2.4. Regulatory framework
- 9.4.3. China
  - 9.4.3.1. Key country dynamics
  - 9.4.3.2. China in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.4.3.3. Competitive/ market scenario
  - 9.4.3.4. Regulatory framework
- 9.4.4. India
  - 9.4.4.1. Key country dynamics
  - 9.4.4.2. India in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.4.4.3. Competitive/ market scenario
  - 9.4.4.4. Regulatory framework
- 9.4.5. Australia
  - 9.4.5.1. Key country dynamics
  - 9.4.5.2. Australia in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.4.5.3. Competitive/ market scenario
  - 9.4.5.4. Regulatory framework
- 9.4.6. Thailand
  - 9.4.6.1. Key country dynamics
  - 9.4.6.2. Thailand in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.4.6.3. Competitive/ market scenario
  - 9.4.6.4. Regulatory framework
- 9.4.7. South Korea
  - 9.4.7.1. Key country dynamics
  - 9.4.7.2. South Korea in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.4.7.3. Competitive/ market scenario
  - 9.4.7.4. Regulatory framework
9.5. Latin America
- 9.5.1. Latin America in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.5.2. Brazil
  - 9.5.2.1. Key country dynamics
  - 9.5.2.2. Brazil in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.5.2.3. Competitive/ market scenario
  - 9.5.2.4. Regulatory framework
- 9.5.3. Mexico
  - 9.5.3.1. Key country dynamics
  - 9.5.3.2. Mexico in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.5.3.3. Competitive/ market scenario
  - 9.5.3.4. Regulatory framework
- 9.5.4. Argentina
  - 9.5.4.1. Key country dynamics
  - 9.5.4.2. Argentina in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.5.4.3. Competitive/ market scenario
  - 9.5.4.4. Regulatory framework
9.6. MEA
- 9.6.1. MEA in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
- 9.6.2. South Africa
  - 9.6.2.1. Key country dynamics
  - 9.6.2.2. South Africa in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.6.2.3. Competitive/ market scenario
  - 9.6.2.4. Regulatory framework
- 9.6.3. Saudi Arabia
  - 9.6.3.1. Key country dynamics
  - 9.6.3.2. Saudi Arabia. in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.6.3.3. Competitive/ market scenario
  - 9.6.3.4. Regulatory framework
- 9.6.4. UAE
  - 9.6.4.1. Key country dynamics
  - 9.6.4.2. UAE in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.6.4.3. Competitive/ market scenario
  - 9.6.4.4. Regulatory framework
- 9.6.5. Kuwait
  - 9.6.5.1. Key country dynamics
  - 9.6.5.2. Kuwait in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
  - 9.6.5.3. Competitive/ market scenario
  - 9.6.5.4. Regulatory framework

Chapter 10. Competitive Landscape

10.1. Company Categorization
10.2. Participant's Overview
10.3. Financial Performance
10.4. Product Benchmarking
- 10.4.1. In vitro diagnostics quality control market share analysis, 2023
- 10.4.2. Company market share, 2023 for plasma-based controls
- 10.4.3. Company market share, 2023 for serum-based controls
- 10.4.4. Company market share, 2023 for whole blood-based controls
10.5. Strategy Mapping
- 10.5.1. Mergers & acquisitions
- 10.5.2. Partnerships & collaborations
- 10.5.3. Expansion
- 10.5.4. Product approval & launch
- 10.5.5. Others

Chapter 11. Company Profiles

11.1. Company Categorization
11.2. Participant's Overview
- 11.2.1. Siemens Healthineers AG
- 11.2.2. Abbott
- 11.2.3. Bio-Rad Laboratories, Inc.
- 11.2.4. Danaher
- 11.2.5. F. Hoffmann-La Roche Ltd
- 11.2.6. Sysmex Corporation
- 11.2.7. QuidelOrtho Corporation
- 11.2.8. Randox Laboratories Ltd
- 11.2.9. Helena Laboratories Corporation
- 11.2.10. Thermo Fisher Scientific, Inc.
- 11.2.11. SeraCare Life Sciences, Inc.
- 11.2.12. BD
- 11.2.13. Merck KGaA
- 11.2.14. QIAGEN
- 11.2.15. Hologic, Inc.
- 11.2.16. Bio-Techne
- 11.2.17. Fortress Diagnostics
- 11.2.18. Microbiologics
- 11.2.19. TRINA BIOREACTIVES AG
- 11.2.20. ConeBioproducts
- 11.2.21. Biorex Diagnostics
11.3. Financial Performance
11.4. Product Benchmarking

Product Code: 978-1-68038-925-8

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 In vitro diagnostics quality control market revenue estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 4 In vitro diagnostics quality control market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
Table 5 In vitro diagnostics quality control market revenue estimates and forecast, by application, 2018 - 2030 (USD Million)
Table 6 In vitro diagnostics quality control market revenue estimates and forecast, by manufacturer type, 2018 - 2030 (USD Million)
Table 7 In vitro diagnostics quality control market revenue estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 8 The classification of levels of IVD in South Africa
Table 9 Company market share, 2023

List of Figures

Fig. 1 In vitro diagnostics quality control market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Product and type segment snapshot
Fig. 11 Application and manufacturer type segment snapshot
Fig. 12 End-use segment snapshot
Fig. 13 Competitive landscape snapshot
Fig. 14 In vitro diagnostics market value, 2023 (USD Billion)
Fig. 15 Market dynamics
Fig. 16 PESTEL analysis
Fig. 17 Porter's five forces analysis
Fig. 18 In vitro diagnostics quality control market: Product outlook and key takeaways
Fig. 19 In vitro diagnostics quality control market: Product movement analysis
Fig. 20 Controls market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Controls market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 22 Total protein estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Total protein market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 24 Albumin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Albumin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 26 Blood urea nitrogen estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Blood urea market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 28 Uric acid market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Uric acid market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 30 Creatinine estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Creatinine market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 32 Sodium market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Sodium market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 34 Potassium estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Potassium market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 36 Chloride market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Chloride market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 38 Calcium estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Calcium market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 40 Magnesium market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 magnesium market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 42 Inorganic phosphorus estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Inorganic phosphorous market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 44 Aspartate transaminase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Aspartate transaminase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 46 Creatine kinase estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Creatine market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 48 Gamma glutamyl transferase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Gamma glutamyl market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 50 Total bilirubin estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Total bilirubin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 52 Glucose market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Glucose market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 54 C-reactive market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 C-reactive market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 56 Iron market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Iron market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 58 Alanine transaminase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Alanine transaminase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 60 Alkaline phosphatase estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Alkaline phosphatase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 62 Alpha amylase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Alpha amylase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 64 Total cholesterol market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Total cholesterol market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 66 Triglyceride estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Triglyceride market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 68 Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 70 Immunoglobulin G estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Immunoglobulin G market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 72 Immunoglobulin A market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Immunoglobulin A market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 74 Immunoglobulin M market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Immunoglobulin M market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 76 Complement 3market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Complement 3 market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 78 Complement 4 estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Complement 4 market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 80 Rheumatoid factor market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Rheumatoid factor market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 82 Anti-streptolysin -O market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Anti-streptolysin -O market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 84 Beta 2 microglobulin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Beta 2 microglobulin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 86 Cystatin-C market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 Cystatin-C market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 88 Myoglobin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 Myoglobin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 90 Troponin T and I market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 91 Troponin T and I market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 92 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 93 Others market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 94 Calibrators market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 95 Calibrators market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 96 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 97 Others market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 98 In vitro diagnostics quality control market: type movement analysis
Fig. 99 In vitro diagnostics quality control market: type outlook and key takeaways
Fig. 100 Quality controls market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 101 Quality controls assurance services estimates and forecast, 2018 - 2030 (USD Million)
Fig. 102 Plasma-based control market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 103 Plasma-based control market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 104 Serum-based control estimates and forecast, 2018 - 2030 (USD Million)
Fig. 105 Serum-based control market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 106 Whole blood-based control market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 107 Whole blood-based control market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 108 Others estimates and forecast, 2018 - 2030 (USD Million)
Fig. 109 Others estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 110 Quality assurance services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 111 Data management solutions market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 112 In vitro diagnostics quality control market: Application movement analysis
Fig. 113 In vitro diagnostics quality control market: Application outlook and key takeaways
Fig. 114 Immunochemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 115 Immunochemistry market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 116 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 117 Hematology market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 118 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 119 Clinical chemistry market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 120 Alkaline phosphatase (ALP) Molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
Fig. 121 Alkaline phosphatase (ALP) market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 122 Alanine transaminase (ALT) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 123 Alanine transaminase (ALT) market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 124 Aspartate transaminase (AST) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 125 Aspartate transaminase (AST) phosphatase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 126 Creatine kinase MB (CK-MB) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 127 Creatine kinase MB (CK-MB) market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 128 Albumin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 129 Albumin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 130 Creatinine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 131 Creatinine market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 132 Glucose market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 133 Glucose market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 134 Triglycerides market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 135 Triglycerides market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 136 Amylase market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 137 Amylase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 138 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 139 Others market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 140 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 141 Molecular diagnostics market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 142 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 143 Coagulation market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 144 Microbiology estimates and forecast, 2018 - 2030 (USD Million)
Fig. 145 Microbiology market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 146 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 147 Others market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
Fig. 148 In vitro diagnostics quality control market: Manufacturer type movement Analysis
Fig. 149 In vitro diagnostics quality control market: Manufacturer type outlook and key takeaways
Fig. 150 Third-party controls market estimates and forecasts, 2018 - 2030
Fig. 151 Independent controls market estimates and forecasts, 2018 - 2030
Fig. 152 Instrument specific controls market estimates and forecasts,2018 - 2030
Fig. 153 OEM controls market estimates and forecasts,2018 - 2030
Fig. 154 In vitro diagnostics quality control market: End-use movement Analysis
Fig. 155 In vitro diagnostics quality control market: End-use outlook and key takeaways
Fig. 156 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 157 Laboratories market estimates and forecasts,2018 - 2030
Fig. 158 Home Care market estimates and forecasts, 2018 - 2030
Fig. 159 Others market estimates and forecasts,2018 - 2030
Fig. 160 In-vitro diagnostics quality control market revenue, by region, 2023 & 2030 (USD Million)
Fig. 161 Regional marketplace: key takeaways
Fig. 162 Regional marketplace: key takeaways
Fig. 163 North America in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 164 Key country dynamics
Fig. 165 U.S. in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 166 Key country dynamics
Fig. 167 Canada in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 168 Europe in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 169 Key country dynamics
Fig. 170 UK in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 171 Key country dynamics
Fig. 172 Germany in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 173 Key country dynamics
Fig. 174 France in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 175 Key country dynamics
Fig. 176 Italy in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 177 Key country dynamics
Fig. 178 Spain in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 179 Key country dynamics
Fig. 180 Denmark in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 181 Key country dynamics
Fig. 182 Sweden in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 183 Key country dynamics
Fig. 184 Norway in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 185 Rest of Europe in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 186 Asia Pacific in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 187 Key country dynamics
Fig. 188 Japan in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 189 Key country dynamics
Fig. 190 China in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 191 Key country dynamics
Fig. 192 India in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 193 Key country dynamics
Fig. 194 Australia vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 195 Key country dynamics
Fig. 196 Thailand in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 197 Key country dynamics
Fig. 198 South Korea in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 199 Rest of Asia Pacific in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 200 Latin America in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 201 Key country dynamics
Fig. 202 Brazil in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 203 Key country dynamics
Fig. 204 Mexico in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 205 Key country dynamics
Fig. 206 Argentina in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 207 Rest of Latin America in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 208 MEA in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 209 Key country dynamics
Fig. 210 South Africa in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 211 Key country dynamics
Fig. 212 Saudi Arabia in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 213 Key country dynamics
Fig. 214 UAE in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 215 Key country dynamics
Fig. 216 Kuwait in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 217 Rest of MEA in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
Fig. 218 Key company categorization
Fig. 219 In vitro diagnostics quality control market share analysis, 2023
Fig. 220 Company market share, 2023 for plasma-based controls
Fig. 221 Company market share, 2023 for serum-based controls
Fig. 222 Company market share, 2023 for whole blood-based controls
Fig. 223 Strategy mapping

In Vitro Diagnostics Quality Control Market Size, Share & Trends Analysis Report By Product, By Type, By Application, By Manufacturer Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Description

Table of Contents

List of Tables

In Vitro Diagnostics Quality Control Market Growth & Trends:

In Vitro Diagnostics Quality Control Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends & Scope

Chapter 4. In Vitro Diagnostics Quality Control Market: Segment Analysis, by Product, 2018 - 2030 (USD Million)

Chapter 5. In Vitro Diagnostics Quality Control Market: Segment Analysis, by Type, 2018 - 2030 (USD Million)

Chapter 6. In Vitro Diagnostics Quality Control Market: By Application Estimates & Trend Analysis

Chapter 7. In Vitro Diagnostics Quality Control Market: By Manufacturer Type Estimates & Trend Analysis

Chapter 8. In Vitro Diagnostics Quality Control Market: End-use Estimates & Trend Analysis

Chapter 9. In Vitro Diagnostics Quality Control Market: Regional Estimates & Trend Analysis, by Product, Type, Application, Manufacturer Type, and End-use

Chapter 10. Competitive Landscape

Chapter 11. Company Profiles

List of Tables

List of Figures